Sol J. Barer, Director at NexImmune, Inc. (NEXI), bought 277,570 shares at $17.00 ($1.0M) on 2021-02-17, disclosed to the SEC on 2021-02-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 217,570 | $0 | 0.0% |
| 2 | $17.00 | 60,000 | $1.0M | 100.0% |
| Total | $3.67 avg | 277,570 | $1.0M | 100% |
| Filing → |
| NEXI | BUY | 2022-06-02 | $312K | — | Filing → |
| NEXI | BUY | 2022-03-24 | $27K | — | Filing → |
| NEXI | BUY | 2022-03-23 | $72K | — | Filing → |